MétaCan
Menu
Back to cohort

Dalteparin for the Prevention of Recurrence of Placental-Mediated Complications of Pregnancy in Women Without Thrombophilia: A Pilot Randomized Controlled Trial

2009· article· en· W2061289257 on OpenAlexaff
Évelyne Rey, Pierre Y. Garneau, Matthias David, Robert Gauthier, L. Leduc, Nicole Michon, Francine Morin, C. Demers, Susan R. Kahn, Laura A. Magee, Marc Rodger

Bibliographic record

VenueObstetrical & Gynecological Survey · 2009
Typearticle
Languageen
FieldMedicine
TopicBlood Coagulation and Thrombosis Mechanisms
Canadian institutionsOttawa HospitalB.C. Women's Hospital & Health CentreJewish General HospitalHôpital de l'Enfant-JésusHôpital Maisonneuve-RosemontCentre Hospitalier Universitaire Sainte-Justine
Fundersnot available
KeywordsMedicineThrombophiliaObstetricsPregnancyRandomized controlled trialPreeclampsiaOdds ratioLow molecular weight heparinRandomizationGestationHeparinGynecologyThrombosisSurgeryInternal medicine

Abstract

fetched live from OpenAlex

Considerable maternal and perinatal mortality and morbidity are associated with placental-mediated pregnancy complications. Preventative options are limited. Because thrombosis is frequently observed in the uteroplacental circulation of women with placental-mediated pregnancy complications, a number of studies have investigated anticoagulation therapy using unfractionated heparin or low-molecular-weight heparin as a preventative option. Most such studies were conducted in women with thrombophilia; the limited data available for women without thrombophilia are unconvincing. This pilot randomized controlled trial evaluated the effectiveness of dalteparin, a low-molecular-weight heparin, in preventing the recurrence of placental-mediated pregnancy complications in women without thrombophilia who are at high risk for these complications. A total of 114 pregnant women were randomized to receive dalteparin (study group, n = 57) or no dalteparin (control group, n = 57). Inclusion criteria at randomization were gestational age <17 weeks, absence of thrombophilia, and occurrence in the immediate previous pregnancy of one or more of the following: severe preeclampsia, unexplained newborn weight ≤ the fifth percentile, abruptio placentae, or unexplained intrauterine death. Women in the study group received dalteparin for 23.0 ± 7.0 weeks. The primary outcome was a composite of one or more of the following: severe preeclampsia, newborn weight ≤ the fifth percentile or major abruptio placentae resulting in delivery before 34 weeks’ gestation. Data were available for 110 women in the final analysis. The primary outcome occurred less frequently in the study group than the control group (5.5% [3 of 55] vs. 23.6% [13 of 55]); the adjusted odds ratio was 0.15, with a 95% confidence interval of 0.03–0.70). No statistically significant differences between the 2 groups were found for the secondary outcomes of nonsevere preeclampsia, birth weight between sixth and 10th percentile and gestational age at delivery. Neither heparin-induced thrombocytopenia nor hemorrhage was observed in the women receiving dalteparin. The findings in this pilot study show that the recurrence of placental-mediated complications in women without thrombophilia is reduced by prophylactic doses of dalteparin, but the results require confirmation in larger randomized trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.028
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.342
Threshold uncertainty score0.980

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.028
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.078
GPT teacher head0.342
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations10
Published2009
Admission routes1
Has abstractyes

Explore more

Same venueObstetrical & Gynecological SurveySame topicBlood Coagulation and Thrombosis MechanismsFrench-language works237,207